Haemonetics Corporation (HAE) /
The revenue of Haemonetics Corporation over the past 10 years
Chart Haemonetics Corporation: revenue, fiscal 2017–2026 Open the chart →Haemonetics Corporation reported revenue of $1.33B in fiscal 2026, the latest fiscal year on file. In fiscal 2017 it was $886.12M — up 51% over 9 years. Year over year, revenue rose 7 times and fell twice. In these years the highest was $1.36B in fiscal 2025; the lowest $870.46M in fiscal 2021. The largest one-year move was in fiscal 2023: up 18%, from $993.2M to $1.17B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2026ended Mar 28, 2026 | $1.33B |
| 2025ended Mar 29, 2025 | $1.36B |
| 2024ended Mar 30, 2024 | $1.31B |
| 2023ended Apr 1, 2023 | $1.17B |
| 2022ended Apr 2, 2022 | $993.2M |
| 2021ended Apr 3, 2021 | $870.46M |
| 2020ended Mar 28, 2020 | $988.48M |
| 2019ended Mar 30, 2019 | $967.58M |
| 2018ended Mar 31, 2018 | $903.92M |
| 2017ended Apr 1, 2017 | $886.12M |
Fiscal years as Haemonetics Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Haemonetics Corporation
- The profitability of Haemonetics Corporation
- The cash flow of Haemonetics Corporation
- The debt of Haemonetics Corporation
- All of Haemonetics Corporation's financials, charted
Companies of a similar size
- BXSLBlackstone Secured Lending Fund
- SRRKSCHOLAR ROCK HOLDING CORPORATION
- EXPEAGLE MATERIALS INC
- NJRNEW JERSEY RESOURCES CORPORATION
- CGONCG Oncology, Inc.
Not investment advice. This page shows what Haemonetics Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.